1. Home
  2. AVDL vs ACEL Comparison

AVDL vs ACEL Comparison

Compare AVDL & ACEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • ACEL
  • Stock Information
  • Founded
  • AVDL 2015
  • ACEL 2009
  • Country
  • AVDL Ireland
  • ACEL United States
  • Employees
  • AVDL N/A
  • ACEL N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • ACEL Services-Misc. Amusement & Recreation
  • Sector
  • AVDL Health Care
  • ACEL Consumer Discretionary
  • Exchange
  • AVDL Nasdaq
  • ACEL Nasdaq
  • Market Cap
  • AVDL 861.4M
  • ACEL 952.2M
  • IPO Year
  • AVDL 1996
  • ACEL N/A
  • Fundamental
  • Price
  • AVDL $10.83
  • ACEL $12.13
  • Analyst Decision
  • AVDL Strong Buy
  • ACEL Buy
  • Analyst Count
  • AVDL 7
  • ACEL 1
  • Target Price
  • AVDL $18.71
  • ACEL $16.00
  • AVG Volume (30 Days)
  • AVDL 1.6M
  • ACEL 227.6K
  • Earning Date
  • AVDL 08-07-2025
  • ACEL 07-29-2025
  • Dividend Yield
  • AVDL N/A
  • ACEL N/A
  • EPS Growth
  • AVDL N/A
  • ACEL N/A
  • EPS
  • AVDL N/A
  • ACEL 0.49
  • Revenue
  • AVDL $194,450,000.00
  • ACEL $1,253,067,000.00
  • Revenue This Year
  • AVDL $56.86
  • ACEL $9.02
  • Revenue Next Year
  • AVDL $30.45
  • ACEL $4.84
  • P/E Ratio
  • AVDL N/A
  • ACEL $24.69
  • Revenue Growth
  • AVDL 252.64
  • ACEL 6.28
  • 52 Week Low
  • AVDL $6.38
  • ACEL $9.02
  • 52 Week High
  • AVDL $17.30
  • ACEL $12.96
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 72.02
  • ACEL 58.44
  • Support Level
  • AVDL $8.74
  • ACEL $12.03
  • Resistance Level
  • AVDL $9.56
  • ACEL $12.39
  • Average True Range (ATR)
  • AVDL 0.41
  • ACEL 0.22
  • MACD
  • AVDL 0.18
  • ACEL -0.01
  • Stochastic Oscillator
  • AVDL 89.88
  • ACEL 61.04

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About ACEL Accel Entertainment Inc.

Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.

Share on Social Networks: